Breaking News Instant updates and real-time market news.

AVXL

Anavex

$2.91

-0.1 (-3.32%)

07:07
10/09/19
10/09
07:07
10/09/19
07:07

Anavex announces initiation of ATTENTION-AD ANAVEX 2-73 extension study

Anavex Life Sciences Corp. announced the initiation of the ATTENTION-AD, a long-term extension study for patients with Early Alzheimer's disease and treated with ANAVEX 2-73. The ATTENTION-AD study, which is an extension of the Phase 2b/3 ANAVEX 2-73-AD-004 clinical study currently underway, will give AD patients an opportunity to continue their treatment. This study is expected to last two years for patients included in the ANAVEX 2-73-AD-004 study, once they have completed the placebo-controlled 48-week Phase 2b/3 trial. ATTENTION-AD will be conducted in parallel with the Phase 2b/3 ANAVEX 2-73-AD-004 study. All patients who participate in the Phase 2b/3 ANAVEX 2-73-AD-004 study will be eligible to participate also in the ATTENTION-AD study under a voluntary open label extension protocol.

AVXL Anavex
$2.91

-0.1 (-3.32%)

01/28/19
ROTH
01/28/19
INITIATION
Target $10
ROTH
Buy
Anavex resumed with a Buy at Roth Capital
Roth Capital analyst Jotin Marango resumed coverage of Anavex with a Buy rating and $10 price target. The analyst likes the breadth and optionality of the Anavex pipeline, which blends together a non-traditional neuro target, biomarker-guided clinical strategy, orphan neurodevelopmental disorders, as well as canonical neurodegenerative diseases.
06/18/19
JANY
06/18/19
INITIATION
JANY
Buy
Anavex initiated with a Buy at Janney Montgomery Scott
07/24/19
DAWS
07/24/19
INITIATION
Target $16
DAWS
Buy
Anavex initiated with a Buy at Dawson James
Dawson James analyst Jason Kolbert initiated Anavex with a Buy and $16 price target.
08/01/19
JANY
08/01/19
NO CHANGE
JANY
Buy
Anavex DSMB review outcome a positive sign, says Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong called it a "positive sign" for ANAVEX 2-73 that the Independent Data Safety Monitoring Board for the company's U.S. Phase 2 Rett syndrome study recommended continuation of the study without modification following a review of the preliminary data. The fact that the company's press release said the board reviewed both efficacy and safety data leads Zhong to believe the study has passed futility analysis, he noted. The analyst, who said he is optimistic that 2-73 could demonstrate efficacy in neurodegenerative and neurodevelopmental disorders, keeps a Buy rating on Avanex shares.

TODAY'S FREE FLY STORIES

SDC

SmileDirectClub

$10.19

0.685 (7.21%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Recommendations
SmileDirectClub analyst commentary  »

Guggenheim says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HEXO

Hexo

$2.54

-0.05 (-1.93%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Hot Stocks
Breaking Hot Stocks news story on Hexo »

Hexo Corp trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

11:37
10/23/19
10/23
11:37
10/23/19
11:37
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:37
10/23/19
10/23
11:37
10/23/19
11:37
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

SAVE

Spirit Airlines

$37.33

0.08 (0.21%)

, EADSY

Airbus

$0.00

(0.00%)

11:33
10/23/19
10/23
11:33
10/23/19
11:33
Periodicals
Spirit Airlines near deal for as many as 100 Airbus A320 jets, Reuters says »

Spirit Airlines (SAVE) is…

SAVE

Spirit Airlines

$37.33

0.08 (0.21%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 13

    Nov

KAMN

Kaman

$58.38

-0.2 (-0.34%)

11:33
10/23/19
10/23
11:33
10/23/19
11:33
Hot Stocks
Kaman executes long term agreement with Winglet Technology »

Kaman Composites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

TWTR

Twitter

$38.93

0.11 (0.28%)

11:32
10/23/19
10/23
11:32
10/23/19
11:32
Earnings
Fly Intel: What to watch in Twitter earnings report »

Twitter (TWTR) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

ABMD

Abiomed

$175.20

4.45 (2.61%)

, ABT

Abbott

$81.49

0.95 (1.18%)

11:29
10/23/19
10/23
11:29
10/23/19
11:29
Recommendations
Trial for potential Abiomed competition pushed back a year, says Piper Jaffray »

This morning, the primary…

ABMD

Abiomed

$175.20

4.45 (2.61%)

ABT

Abbott

$81.49

0.95 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

HEMA

HemaCare Corp.

$0.00

(0.00%)

11:27
10/23/19
10/23
11:27
10/23/19
11:27
Periodicals
Breaking Periodicals news story on HemaCare Corp. »

HemaCare Corp. working…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$175.20

4.45 (2.61%)

, ABT

Abbott

$81.52

0.98 (1.22%)

11:27
10/23/19
10/23
11:27
10/23/19
11:27
Hot Stocks
Abiomed jumps after Abbott heart pump trial pushed back one year »

An update today on…

ABMD

Abiomed

$175.20

4.45 (2.61%)

ABT

Abbott

$81.52

0.98 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

MGNX

MacroGenics

$9.87

-1.17 (-10.60%)

, ZYME

Zymeworks

$30.25

-0.26 (-0.85%)

11:26
10/23/19
10/23
11:26
10/23/19
11:26
Recommendations
MacroGenics, Zymeworks analyst commentary  »

MacroGenics price target…

MGNX

MacroGenics

$9.87

-1.17 (-10.60%)

ZYME

Zymeworks

$30.25

-0.26 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

TRU

TransUnion

$82.71

2.31 (2.87%)

11:26
10/23/19
10/23
11:26
10/23/19
11:26
Conference/Events
TransUnion management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 19

    Nov

CVM

CEL-SCI

$7.35

(0.00%)

11:25
10/23/19
10/23
11:25
10/23/19
11:25
Options
Cel Sci call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCG

NRC Group

$13.00

(0.00%)

, ECOL

US Ecology

$66.75

0.245 (0.37%)

11:25
10/23/19
10/23
11:25
10/23/19
11:25
Conference/Events
US Ecology to host special shareholder meeting »

Special Shareholder…

NRCG

NRC Group

$13.00

(0.00%)

ECOL

US Ecology

$66.75

0.245 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 31

    Oct

SNAP

Snap

$13.24

-0.76 (-5.43%)

11:19
10/23/19
10/23
11:19
10/23/19
11:19
Hot Stocks
Snap says DOJ, SEC no longer pursuing investigations of IPO disclosures »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/23/19
10/23
11:17
10/23/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/23/19
10/23
11:16
10/23/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$184.34

2.07 (1.14%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Hot Stocks
Facebook shares up 1.6% as CEO testifies on Capitol Hill »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

CNC

Centene

$48.49

-0.28 (-0.57%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Options
Centene call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

D

Dominion

$83.07

0.29 (0.35%)

11:03
10/23/19
10/23
11:03
10/23/19
11:03
Hot Stocks
Dominion, Smithfield Foods double investment in renewable natural gas to $500M »

Dominion Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

BA

Boeing

$345.52

8.07 (2.39%)

11:02
10/23/19
10/23
11:02
10/23/19
11:02
Hot Stocks
Boeing CFO says it will take 'several quarters' to deliver parked 737 MAX jets »

CFO Greg Smith says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$345.79

8.34 (2.47%)

11:00
10/23/19
10/23
11:00
10/23/19
11:00
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says studying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MMM

3M

$166.93

-0.63 (-0.38%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GLOG

GasLog

$14.29

0.325 (2.33%)

, GLOP

GasLog Partners

$20.24

0.35 (1.76%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Conference/Events
Deutsche Bank shipping analyst to hold analyst/industry conference call »

Analysts, along with…

GLOG

GasLog

$14.29

0.325 (2.33%)

GLOP

GasLog Partners

$20.24

0.35 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

BA

Boeing

$346.26

8.81 (2.61%)

10:54
10/23/19
10/23
10:54
10/23/19
10:54
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.